Loading...

TherapeuticsMD, Inc.

TXMD•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$2.19
$0.010(0.46%)
U.S. Market opens in NaNh NaNm

TherapeuticsMD, Inc. (TXMD) Stock Overview

Explore TherapeuticsMD, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap24.5M
P/E Ratio-44.73
EPS (TTM)$-0.06
ROE-0.02%
Fundamental Analysis

AI Price Forecasts

1 Month$2.47
3 Months$3.57
1 Year Target$1.48

TXMD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of TherapeuticsMD, Inc. (TXMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.59, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.48.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -44.73 and a market capitalization of 24.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.46%
5-Day Change
6.83%
1-Month Change
-4.37%
3-Month Change
-16.09%
6-Month Change
69.77%
Year-to-Date (YTD) Change
34.36%
1-Year Change
92.11%
3-Year Change
-40.81%
5-Year Change
-96.41%
All-Time (Max) Change
-99.95%

Contact Information

https://www.therapeuticsmd.com
561 961 1900
951 Yamato Road, Boca Raton, FL, 33431

Company Facts

1 Employees
IPO DateMay 9, 2007
CountryUS
Actively Trading

Frequently Asked Questions